Singapore histopathology services market was valued at $5,583
million in 2016, and is expected to reach $8,766 million by 2023, growing at a
CAGR of 6.6% from 2017 to 2023. Histopathology is a branch of pathology, which
deals with the study of changes in tissue occurring due to a disease. In this
procedure, suspected tissues (for a disease) are removed from a patient's body
and examined in a laboratory to study manifestations of the disease.
Download Sample
Report: https://www.alliedmarketresearch.com/request-sample/4103
Increase in prevalence of cancer & other chronic
disorders, rapid growth in geriatric population in Europe, and rise in public
awareness towards disease screening drive the growth of the Europe
histopathology services market. However, limitations of histopathology, as the
technique is subjected to human error during analysis and preparation of tissue
slides, and dearth of pathologists & medical laboratory scientists in the
UK are expected to impede the Singapore market growth. On the contrary, increase in
demand for personalized medicine is expected to offer ample opportunities for
market expansion during the forecast period.
The surgical specimen segment accounted for nearly half of
the market share in 2016, and is expected to maintain its dominant position
during the analysis period, owing to increase in number of surgical procedures
across Europe.
Get Detail Report https://www.alliedmarketresearch.com/europe-histopathology-lab-market
0 Comments